SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Baan Robert)
 

Search: WFRF:(Baan Robert) > (2004) > Epidemiological eva...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Epidemiological evaluation of cytogenetic biomarkers as potential surrogate end-points for cancer.

Hagmar, Lars (author)
Strömberg, Ulf (author)
Lund University,Lunds universitet,Avdelningen för arbets- och miljömedicin,Institutionen för laboratoriemedicin,Medicinska fakulteten,Division of Occupational and Environmental Medicine, Lund University,Department of Laboratory Medicine,Faculty of Medicine
Tinnerberg, Håkan (author)
Lund University,Lunds universitet,Avdelningen för arbets- och miljömedicin,Institutionen för laboratoriemedicin,Medicinska fakulteten,Division of Occupational and Environmental Medicine, Lund University,Department of Laboratory Medicine,Faculty of Medicine
show more...
Mikoczy, Zoli (author)
Lund University,Lunds universitet,Avdelningen för arbets- och miljömedicin,Institutionen för laboratoriemedicin,Medicinska fakulteten,Division of Occupational and Environmental Medicine, Lund University,Department of Laboratory Medicine,Faculty of Medicine
Buffler, Patricia A (editor)
Rice, Jerry M (editor)
Baan, Robert (editor)
Bird, Michael G (editor)
Boffetta, Paolo (editor)
show less...
 (creator_code:org_t)
2004
2004
English.
In: Mechanisms of Carcinogenesis (IARC Sci. Publ. ; 157). - 9283221575 - 9789283221579 ; :157, s. 207-215
  • Book chapter (other academic/artistic)
Abstract Subject headings
Close  
  • Various occupational exposures have been monitored by chromosomal aberrations, sister chromatid exchanges and micronuclei in peripheral blood lymphocytes. During the last decade, epidemiological studies have evaluated whether any of these markers foreshadows cancer risk. Results from Nordic, Italian and Czech cohorts support an approximately twofold cancer risk among subjects with high frequencies of chromosomal aberrations, but no such association was seen for any of the other biomarkers. The estimated attributable proportion of high frequencies of chromosomal aberrations for overall cancer risk is 0.25, which gives a quantitative estimate of the chromosomal aberration assay as a surrogate endpoint of cancer. The results from the different cohort studies are contradictory in terms of whether or not the predictive value of the chromosomal aberration assay for cancer is differential with respect to occupational exposure to clastogens. Genetic susceptibility factors are known to affect the frequency of chromosomal aberrations in peripheral blood lymphocytes. It is quite possible that such factors might also affect the frequency of chromosomal aberrations directly or might modify the impact of exposures to clastogen. There is no other biomarker for general cancer risk that is applicable to healthy subjects from the general population with such a high attributable proportion. However, at present only a simplified and tentative model can be proposed for the role of the chromosomal aberration marker in the pathogenesis of cancer.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Hälsovetenskap -- Arbetsmedicin och miljömedicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Health Sciences -- Occupational Health and Environmental Health (hsv//eng)

Keyword

Non-U.S. Gov't
Support
Neoplasms: genetics
Neoplasms: etiology
Biological Markers
Case-Control Studies
Chromosome Aberrations
Epidemiologic Studies
Human
Cohort Studies

Publication and Content Type

kap (subject category)
vet (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view